EarlySense, which monitors a series of vital signs in hospitals and home health care settings, is among four companies that will share $2 million in grants from the Global Cardiovascular Innovation Center (GCIC).
BioOhio -- Ohio's bioscience industry developer -- and the Global Cardiovascular Innovation Center (GCIC) housed at the Cleveland Clinic have published a bigger and better online directory of the state's companies, organizations and research centers that are involved in the biosciences. BioOhio will hold a webinar at 10 a.m. on Wednesday, Sept. 16, to demonstrate directory searches and queries, and answer questions.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The center invested a total of $1 million in Cardiostar Ltd., Sensible Medical Innovations Ltd. and Vasostar Ltd. Cardiostar is developing a non-invasive way to monitor blood-pressure beat-to-beat, Sensible Medical's device works during congestive heart failure to, among other things, more quickly detect lungs filling with fluid; and Vasostar's catheter would better break up artery blockages known as total chronic occlusion.
An Ohio State University researcher is developing an MRI-compatible treadmill that could better measure heart function and blood flow at the peak of stress. The device, which could cut down on multiple tests and catch some heart problems earlier, may be ready for clinical testing in three months.
The Global Cardiovascular Innovation Center in Cleveland is looking for young companies that need financial and developmental help to take their heart-related products to market. The center's next grant round starts on May 8.